John W. Shiver

This profile gathers the share dealings of John W. Shiver across 2 companies, led by Icosavax, Inc. and Novavax Inc. We count 5 filings; the first trade dates from 3 January 2022 and the latest from 10 March 2026.

Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The latest filing, published on 12 March 2026, reports an option exercise in Novavax Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.